On the public citation graph
Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study
0 signed · 172 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archderm.136.7.905openalex-snapshot
Benign Cutaneous Vascular Tumors of Infancy
inferredcites →https://doi.org/10.1001/archderm.143.7.912openalex-snapshot
Poor Adherence to Treatments
inferredcites →https://doi.org/10.1001/archdermatol.2009.259openalex-snapshot
Adherence, the Fourth Dimension in the Geometry of Dermatological Treatment
inferredcites →https://doi.org/10.1001/archdermatol.2010.67openalex-snapshot
Topical Timolol Gel for Infantile Hemangiomas: A Pilot Study
inferredcites →https://doi.org/10.1002/lary.20807openalex-snapshot
Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center
inferredcites →https://doi.org/10.1007/bf02524799openalex-snapshot
Long-Term Efficacy and Safety of Atenolol for Supraventricular Tachycardia in Children
inferredcites →https://doi.org/10.1007/s00246-003-0536-xopenalex-snapshot
Long-Term Efficacy of Atenolol for Atrioventricular Reciprocating Tachycardia in Children Less Than 5 Years Old
inferredcites →https://doi.org/10.1007/s00246-005-1126-xopenalex-snapshot
Medications Used to Manage Supraventricular Tachycardia in the Infant A North American Survey
inferredcites →https://doi.org/10.1007/s00246-010-9819-1openalex-snapshot
Use of a Cardioselective Beta-Blocker for Pediatric Patients With Prolonged QT Syndrome
inferredcites →https://doi.org/10.1007/s00431-012-1928-9openalex-snapshot
Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China
inferredcites →https://doi.org/10.1016/0002-9149(89)90466-9openalex-snapshot
Atenolol in children with supraventricular tachycardia
inferredcites →https://doi.org/10.1016/j.ad.2011.02.009openalex-snapshot
Tratamiento con propranolol oral para hemangiomas infantiles graves: serie de 28 pacientes
inferredcites →https://doi.org/10.1016/j.ad.2011.04.001openalex-snapshot
Hemangiomas de la infancia: pasado, presente y futuro del tratamiento con propranolol
inferredcites →https://doi.org/10.1016/j.ad.2011.05.003openalex-snapshot
Propranolol en hemangiomas infantiles: eficacia clínica, riesgos y recomendaciones
inferredcites →https://doi.org/10.1016/j.ad.2012.01.017openalex-snapshot
Tratamiento de hemangiomas infantiles con propranolol en régimen de control ambulatorio. Estudio prospectivo
inferredcites →https://doi.org/10.1016/j.ad.2012.03.010openalex-snapshot
Oral Propranolol for Treating Infantile Hemangiomas: A Case Series of 57 Patients
inferredcites →https://doi.org/10.1016/j.adengl.2011.02.003openalex-snapshot
Propranolol for the Treatment of Severe Hemangiomas of Infancy: Results From a Series of 28 Patients
inferredcites →https://doi.org/10.1016/j.adengl.2011.04.001openalex-snapshot
Past, Present, and Future of Propranolol for Hemangiomas of Infancy
inferredcites →https://doi.org/10.1016/j.adengl.2012.01.015openalex-snapshot
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations
inferredcites →https://doi.org/10.1016/j.adengl.2012.01.019openalex-snapshot
Outpatient Treatment of Infantile Hemangiomas With Propranolol: A Prospective Study
inferredcites →https://doi.org/10.1016/j.bjps.2010.07.009openalex-snapshot
Propranolol as first-line treatment for rapidly proliferating Infantile Haemangiomas
inferredcites →https://doi.org/10.1016/j.ijporl.2009.12.008openalex-snapshot
Initial experience using propranolol as the sole treatment for infantile airway hemangiomas
inferredcites →https://doi.org/10.1016/j.jaad.2010.06.048openalex-snapshot
Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants
inferredcites →https://doi.org/10.1016/j.jaad.2010.11.056openalex-snapshot
Atenolol: A promising alternative to propranolol for the treatment of hemangiomas
inferredcites →https://doi.org/10.1016/j.jaad.2010.12.040openalex-snapshot
Propranolol for treatment of ulcerated infantile hemangiomas
inferredcites →https://doi.org/10.1016/j.jaad.2011.01.025openalex-snapshot
Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controls
inferredcites →https://doi.org/10.1016/j.sder.2010.03.009openalex-snapshot
Current Management of Infantile Hemangiomas
inferredcites →https://doi.org/10.1016/s0140-6736(10)62226-xopenalex-snapshot
Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies
inferredcites →https://doi.org/10.1056/nejmc0708819openalex-snapshot
Propranolol for Severe Hemangiomas of Infancy
inferredcites →https://doi.org/10.1097/prs.0b013e31827c6fabopenalex-snapshot
Propranolol versus Corticosteroids in the Treatment of Infantile Hemangioma
inferredcites →https://doi.org/10.1111/j.1365-2133.2009.09597.xopenalex-snapshot
Propranolol for complicated infantile haemangiomas: a case series of 30 infants
inferredcites →https://doi.org/10.1111/j.1365-2133.2010.09848.xopenalex-snapshot
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
inferredcites →https://doi.org/10.1111/j.1468-3083.2010.03603.xopenalex-snapshot
Successful treatment of ulcerated haemangioma with propranolol
inferredcites →https://doi.org/10.1111/j.1525-1470.2010.01355.xopenalex-snapshot
Hepatic Infantile Hemangiomas Treated with Oral Propranolol—A Case Series
inferredcites →https://doi.org/10.1111/j.1525-1470.2011.01345.xopenalex-snapshot
Propranolol for Infantile Hemangiomas
inferredcites →https://doi.org/10.1111/pde.12046openalex-snapshot
A Retrospective Study of Propranolol Therapy in 109 Infants with Infantile Hemangioma
inferredcites →https://doi.org/10.1542/peds.2007-2767openalex-snapshot
Growth Characteristics of Infantile Hemangiomas: Implications for Management
inferredcites →https://doi.org/10.1542/peds.2010-0029openalex-snapshot
A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas
inferredcites →https://doi.org/10.1542/peds.2012-1691openalex-snapshot
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
inferredcites →https://doi.org/10.2174/138161208784007644openalex-snapshot
Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4500358openalex-extracted
Dual Controlled Delivery of Furosemide and Atenolol Using the Biodegradable Nano System for Antihypertensive Therapy
inferred← citeshttps://doi.org/10.1001/jamadermatol.2017.0250openalex-snapshot
Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma
inferred← citeshttps://doi.org/10.1001/jamafacial.2016.1188openalex-snapshot
Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas
inferred← citeshttps://doi.org/10.1001/jamaoto.2021.0454openalex-snapshot
Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas
inferred← citeshttps://doi.org/10.1002/14651858.cd006545.pub3openalex-snapshot
Interventions for infantile haemangiomas of the skin
inferred← citeshttps://doi.org/10.1002/14651858.cd011893openalex-snapshot
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants
inferred← citeshttps://doi.org/10.1002/14651858.cd011893.pub2openalex-snapshot
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants
inferred← citeshttps://doi.org/10.1002/jssc.201700252openalex-snapshot
A simple, selective, and sensitive gas chromatography–mass spectrometry method for the analysis of five process‐related impurities in atenolol bulk drug and capsule formulations
inferred← citeshttps://doi.org/10.1002/jvc2.70171openalex-snapshot
The Efficacy and Safety of Atenolol for Treatment of Infantile Hemangioma
inferred← citeshttps://doi.org/10.1002/jvc2.70291openalex-snapshot
Atenolol for Infantile Hemangioma: A Future First‐Line Therapy?
inferred← citeshttps://doi.org/10.1002/med.21984openalex-snapshot
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing
inferred← citeshttps://doi.org/10.1007/978-1-4471-7314-4_2openalex-snapshot
Infantile Hemangioma: New Insights on Pathogenesis and Beta Blockers Mechanisms of Action
inferred← citeshttps://doi.org/10.1007/978-3-030-02023-1_16openalex-snapshot
Vascular Laser and Light Treatments
inferred← citeshttps://doi.org/10.1007/978-3-319-29704-0_4openalex-snapshot
Infantile Hemangiomas of the Eyelids and Orbit
inferred← citeshttps://doi.org/10.1007/978-3-319-60814-3_6openalex-snapshot
Pediatric Dermatology and the Oculoplastic Patient
inferred← citeshttps://doi.org/10.1007/978-981-15-2321-2_5openalex-snapshot
Medical Management of Vascular Lesions: Current and the Future
inferred← citeshttps://doi.org/10.1007/s00105-019-4404-xopenalex-snapshot
Update infantile Hämangiome
inferred← citeshttps://doi.org/10.1007/s00431-015-2570-0openalex-snapshot
Treatment of infantile haemangiomas: recommendations of a European expert group
inferred← citeshttps://doi.org/10.1007/s00431-021-04147-3openalex-snapshot
Sleep behavior of infants with infantile hemangioma treated with propranolol—a cohort study
inferred← citeshttps://doi.org/10.1007/s00431-026-07257-yopenalex-snapshot
Efficacy and safety of interventions for infantile hemangioma compared with oral propranolol: an updated systematic review and bayesian network meta-analysis
inferred← citeshttps://doi.org/10.1007/s00595-025-03211-xopenalex-snapshot
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022
inferred← citeshttps://doi.org/10.1007/s10456-026-10057-5openalex-snapshot
HDAC inhibition reprograms stem cell fate to suppress infantile hemangioma vasculogenesis
inferred← citeshttps://doi.org/10.1007/s11604-019-00885-5openalex-snapshot
Japanese clinical practice guidelines for vascular anomalies 2017
inferred← citeshttps://doi.org/10.1007/s11604-025-01932-0openalex-snapshot
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022
inferred← citeshttps://doi.org/10.1007/s12070-018-1410-8openalex-snapshot
Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate
inferred← citeshttps://doi.org/10.1007/s12519-019-00285-9openalex-snapshot
Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies
inferred← citeshttps://doi.org/10.1007/s40272-021-00477-9openalex-snapshot
Medical Management of Infantile Hemangiomas: An Update
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6275-9.00103-3openalex-snapshot
10.1016/b978-0-7020-6275-9.00103-3
inferred← citeshttps://doi.org/10.1016/j.abd.2024.03.013openalex-snapshot
Brazilian experience with oral atenolol in the treatment of infantile hemangiomas
inferred← citeshttps://doi.org/10.1016/j.ad.2019.03.015openalex-snapshot
Atenolol oral en el manejo del hemangioma infantil: serie de casos de 46 pacientes
inferred← citeshttps://doi.org/10.1016/j.adengl.2019.11.004openalex-snapshot
Oral atenolol for infantile hemangioma: case series of 46 infants
inferred← citeshttps://doi.org/10.1016/j.ajpath.2026.02.008openalex-snapshot
R-Propranolol Promotes the Adipogenesis and Subsequent Apoptosis of Hemangioma Stem Cells through the Protein Kinase RNA-Like Endoplasmic Reticulum Kinase Signaling Pathway
inferred← citeshttps://doi.org/10.1016/j.anpede.2015.10.017openalex-snapshot
Spanish consensus on infantile haemangioma
inferred← citeshttps://doi.org/10.1016/j.anpedi.2015.10.004openalex-snapshot
Consenso español sobre el hemangioma infantil
inferred← citeshttps://doi.org/10.1016/j.envpol.2016.07.041openalex-snapshot
Transformation of atenolol, metoprolol, and carbamazepine in soils: The identification, quantification, and stability of the transformation products and further implications for the environment
inferred← citeshttps://doi.org/10.1016/j.fsc.2015.04.009openalex-snapshot
Evidence-Based Medicine in the Treatment of Infantile Hemangiomas
inferred← citeshttps://doi.org/10.1016/j.jaad.2025.07.017openalex-snapshot
Paradigm shift in the management of infantile hemangiomas in the beta-blocker era: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.105006openalex-snapshot
Dual-controlled delivery of furosemide and atenolol using a biodegradable nanosystem for antihypertensive therapy
inferred← citeshttps://doi.org/10.1016/j.jhazmat.2018.11.006openalex-snapshot
Efficiency and mechanism of atenolol decomposition in Co-FeOOH catalytic ozonation
inferred← citeshttps://doi.org/10.1016/j.jid.2024.01.029openalex-snapshot
KLF2 Orchestrates Pathological Progression of Infantile Hemangioma through Hemangioma Stem Cell Fate Decisions
inferred← citeshttps://doi.org/10.1016/j.jid.2024.06.1275openalex-snapshot
Cell Fate Regulation During the Development of Infantile Hemangioma
inferred← citeshttps://doi.org/10.1016/j.lpm.2025.104291openalex-snapshot
Diagnosis and management of infantile hemangiomas: Tremendous advances over the last 15 years
inferred← citeshttps://doi.org/10.1016/j.otc.2017.09.009openalex-snapshot
Infantile Hemangiomas in the Head and Neck Region
inferred← citeshttps://doi.org/10.1016/j.sempedsurg.2020.150969openalex-snapshot
Infantile and congenital hemangiomas
inferred← citeshttps://doi.org/10.1016/j.survophthal.2019.02.005openalex-snapshot
Current treatment and management of infantile hemangiomas
inferred← citeshttps://doi.org/10.1016/j.vph.2022.107110openalex-snapshot
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro
inferred← citeshttps://doi.org/10.1016/j.yprs.2014.07.014openalex-snapshot
10.1016/j.yprs.2014.07.014
inferred← citeshttps://doi.org/10.1016/s0151-9638(14)70166-8openalex-snapshot
Quoi de neuf en dermatologie pédiatrique ?
inferred← citeshttps://doi.org/10.1038/s41598-018-22787-8openalex-snapshot
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
inferred← citeshttps://doi.org/10.1055/s-0037-1604297openalex-snapshot
Advances in the Medical Management of Vascular Anomalies
inferred← citeshttps://doi.org/10.1055/s-0038-1629264openalex-snapshot
Interdisziplinäre Therapie infantiler Hämangiome
inferred← citeshttps://doi.org/10.1080/17512433.2020.1788938openalex-snapshot
β-blocker therapy for infantile hemangioma
inferred← citeshttps://doi.org/10.1093/ced/llae401openalex-snapshot
Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review
inferred← citeshttps://doi.org/10.1093/med/9780198840787.005.0001openalex-snapshot
Supplementary material A: Commentaries
inferred← citeshttps://doi.org/10.1097/iop.0000000000002507openalex-snapshot
Long-Term Results of Oral Propranolol Treatment Protocol for Periocular Infantile Hemangioma: Should There Be Any Contraindication?
inferred← citeshttps://doi.org/10.1097/jova.0000000000000012openalex-snapshot
Novel Treatment of a Diffuse Infantile Hepatic Hemangioma With a Selective Beta-1 Antagonist
inferred← citeshttps://doi.org/10.1097/md.0000000000003908openalex-snapshot
Oral atenolol therapy for proliferating infantile hemangioma
inferred← citeshttps://doi.org/10.1097/md.0000000000024146openalex-snapshot
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China
inferred← citeshttps://doi.org/10.1097/mop.0000000000000238openalex-snapshot
Beta-blockers for childhood vascular tumors
inferred← citeshttps://doi.org/10.1111/1346-8138.15189openalex-snapshot
Japanese Clinical Practice Guidelines for Vascular Anomalies 2017
inferred← citeshttps://doi.org/10.1111/1346-8138.70093openalex-snapshot
Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022
inferred← citeshttps://doi.org/10.1111/ajd.12966openalex-snapshot
Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review
inferred← citeshttps://doi.org/10.1111/bjd.13535openalex-snapshot
Propranolol for infantile haemangiomas: certain chances, potential risks
inferred← citeshttps://doi.org/10.1111/bjd.13907openalex-snapshot
Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals
inferred← citeshttps://doi.org/10.1111/bjd.14687openalex-snapshot
Ulcerated infantile haemangiomas: the effect of the selective beta-blocker atenolol on wound healing
inferred← citeshttps://doi.org/10.1111/bjd.15317openalex-snapshot
Atenolol treatment for infantile haemangioma
inferred← citeshttps://doi.org/10.1111/bjd.17407openalex-snapshot
Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments
inferred← citeshttps://doi.org/10.1111/ijd.14618openalex-snapshot
Phaces syndrome successfully treated with oral atenolol
inferred← citeshttps://doi.org/10.1111/jdv.15464openalex-snapshot
Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre
inferred← citeshttps://doi.org/10.1111/jocd.70750openalex-snapshot
A Systematic Review and Meta‐Analysis of the Efficacy and Safety of Propranolol Versus Other Drugs in the Treatment of Infantile Hemangioma
inferred← citeshttps://doi.org/10.1111/pde.13177openalex-snapshot
Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study
inferred← citeshttps://doi.org/10.1111/ped.14077openalex-snapshot
Japanese clinical practice guidelines for vascular anomalies 2017
inferred← citeshttps://doi.org/10.1111/ped.15384openalex-snapshot
Application of topical betaxolol to cure superficial infantile hemangioma: A pilot study
inferred← citeshttps://doi.org/10.1111/ped.70333openalex-snapshot
Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis 2022
inferred← citeshttps://doi.org/10.1136/archdischild-2014-306197openalex-snapshot
Incidence and treatment of infantile haemangioma in preterm infants
inferred← citeshttps://doi.org/10.1136/bmjebm-2025-114044openalex-snapshot
Evaluating data extraction error by a large language model from randomised controlled trials: a large-scale empirical study
inferred← citeshttps://doi.org/10.1159/000448396openalex-snapshot
Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases
inferred← citeshttps://doi.org/10.1159/000536144openalex-snapshot
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents
inferred← citeshttps://doi.org/10.1159/000542001openalex-snapshot
Rebound Growth of Infantile Hemangiomas after Propranolol versus Atenolol Treatment: A Retrospective Study
inferred← citeshttps://doi.org/10.11604/pamj.2019.32.155.16760openalex-snapshot
Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
inferred← citeshttps://doi.org/10.11606/t.17.2023.tde-10112023-165514openalex-snapshot
Avaliação in vivo da segurança de tartarato de metoprolol intravítreo em olhos com hemangioma circunscrito de coroide. Estudo fase I
inferred← citeshttps://doi.org/10.1177/00034894221089758openalex-snapshot
Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol
inferred← citeshttps://doi.org/10.12788/j.sder.2016.047openalex-snapshot
Infantile hemangiomas and structural anomalies: PHACE and LUMBAR syndrome
inferred← citeshttps://doi.org/10.12788/j.sder.2016.050openalex-snapshot
Infantile hemangiomas, complications and treatments
inferred← citeshttps://doi.org/10.1371/journal.pone.0138100openalex-snapshot
Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis
inferred← citeshttps://doi.org/10.14238/sp17.6.2016.428-34openalex-snapshot
Efikasi Terapi Topikal Kortikosteroid Ultrapoten, Solusio, dan Gel Timolol Maleat 0,5% Terhadap Hemangioma Infantil Superfisial
inferred← citeshttps://doi.org/10.1517/14740338.2016.1130125openalex-snapshot
Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events – a review of the literature
inferred← citeshttps://doi.org/10.1542/gr.40-3-33openalex-snapshot
Risks With Use of Oral Propranolol for Infantile Hemangioma
inferred← citeshttps://doi.org/10.1542/gr.46-1-6openalex-snapshot
Infantile Hemangiomas: A Comparison of Propranolol and Atenolol Treatment
inferred← citeshttps://doi.org/10.1542/peds.2015-3896openalex-snapshot
Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis
inferred← citeshttps://doi.org/10.1542/peds.2016-0353openalex-snapshot
Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
inferred← citeshttps://doi.org/10.18484/2305-0047.2019.1.81openalex-snapshot
Contemporary Options for Medical Treatment of Pediatric Vascular Lesions
inferred← citeshttps://doi.org/10.21037/atm-20-5359openalex-snapshot
Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients
inferred← citeshttps://doi.org/10.21037/atm.2019.10.47openalex-snapshot
Progress in the treatment of infantile hemangioma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-209620/v1openalex-snapshot
Topical Betaxolol Hydrochloride for the Treatment of Superficial Infantile Hemangiomas: A Single Institutional Retrospective Study
inferred← citeshttps://doi.org/10.2147/phmt.s115528openalex-snapshot
Current perspectives on the optimal management of infantile hemangioma
inferred← citeshttps://doi.org/10.2174/1573396316666200508100038openalex-snapshot
Infantile Hemangioma: An Updated Review
inferred← citeshttps://doi.org/10.2340/actadv.v102.2021openalex-snapshot
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
inferred← citeshttps://doi.org/10.24875/bmhim.19000002openalex-snapshot
Hemangioma infantil: actualización del tratamiento tópico y sistémico
inferred← citeshttps://doi.org/10.29021/spdv.77.1.1008openalex-snapshot
Hemangiomas Infantis e Bloqueadores-Beta: 10 Anos Depois da Revolução Terapêutica
inferred← citeshttps://doi.org/10.3329/dshj.v34i1.51825openalex-snapshot
Oral Atenolol Therapy in the Treatment of Infantile Hemangioma: A Prospective Study
inferred← citeshttps://doi.org/10.33448/rsd-v10i8.16968openalex-snapshot
O uso do propranolol na terapêutica do hemangioma infantil
inferred← citeshttps://doi.org/10.33696/pharmacol.4.036openalex-snapshot
Off Label Use as an Indicator of Therapeutic Need in Pediatrics
inferred← citeshttps://doi.org/10.3389/fonc.2022.1064048openalex-snapshot
Management of infantile hemangiomas: Recent advances
inferred← citeshttps://doi.org/10.3389/fonc.2023.1132344openalex-snapshot
Integrated nontargeted and targeted metabolomics analyses amino acids metabolism in infantile hemangioma
inferred← citeshttps://doi.org/10.3389/fsurg.2014.00038openalex-snapshot
Biology of Infantile Hemangioma
inferred← citeshttps://doi.org/10.3390/children6050066openalex-snapshot
Pediatric Compounding Pharmacy: Taking on the Responsibility of Providing Quality Customized Prescriptions
inferred← citeshttps://doi.org/10.3390/jcm8020268openalex-snapshot
Central Nervous System Effects of Oral Propranolol for Infantile Hemangioma: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3892/etm.2020.8842openalex-snapshot
Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta‑analysis
inferred← citeshttps://doi.org/10.4103/ijd.ijd_867_22openalex-snapshot
Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma
inferred← citeshttps://doi.org/10.4103/ijdd.ijdd_17_17openalex-snapshot
Use of Propranolol in Infantile Hemangioma
inferred← citeshttps://doi.org/10.4103/ijdvl.ijdvl_220_16openalex-snapshot
Beta-blockers in dermatology
inferred← citeshttps://doi.org/10.4103/ijpd.ijpd_10_18openalex-snapshot
Propranolol: A miracle drug for infantile hemangioma associated with PHACES syndrome
inferred← citeshttps://doi.org/10.4103/jiaps.jiaps_3_21openalex-snapshot
Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma
inferred← citeshttps://doi.org/10.4149/neo_2015_118openalex-snapshot
β-blockers in the treatment of periocular infantile capillary haemangioma
inferred← citeshttps://doi.org/10.4330/wjc.v8.i1.74openalex-snapshot
Cardiovascular drugs in the treatment of infantile hemangioma
inferred← citeshttps://doi.org/10.5070/d3217028111openalex-snapshot
Beta blocker treatment for infantile hemangiomas
inferred← citeshttps://doi.org/10.5070/d3249041401openalex-snapshot
Infantile hemangiomas: our current understanding and treatment options
inferred← citeshttps://doi.org/10.5314/wjd.v5.i1.4openalex-snapshot
Propranolol for infantile hemangioma: Current state of affairs
inferred← citeshttps://doi.org/10.53986/ibjm.2022.0025openalex-snapshot
Current management of complicated infantile hemangiomas: Atenolol or Propranolol?
inferred← citeshttps://doi.org/10.5863/1551-6776-22.2.124openalex-snapshot
Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma
inferred← citeshttps://doi.org/10.5867/medwave.2023.11.2753openalex-snapshot
Oral atenolol compared to oral propranolol for infantile hemangioma
inferred← citeshttps://doi.org/10.7573/dic.2020-12-6openalex-snapshot
Paediatrics: how to manage infantile haemangioma
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.